General form of registration statement for all companies including face-amount certificate companies

Share-Based Payment and Related Stock Option Plan

v3.21.2
Share-Based Payment and Related Stock Option Plan
9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]    
Share-Based Payment and Related Stock Option Plan
NOTE 10 – SHARE-BASED PAYMENT AND RELATED STOCK
 
OPTION PLAN
During 2020, the Company granted awards to certain employees
 
and Board members of the Company. Under the 2014 Equity Incentive Plan (the “Plan”), the Board is authorized to grant stock options to eligible employees and directors of the Company. The fair value of the options was expensed
on
a straight-line basis over the requisite service period, which is generally the vesting period.
In connection with the Business Combination a modification in the existing terms of the options was introduced to add contingent cash-settlement feature pursuant to which each option holder entered into option cancellation agreement (“Cancellation Agreements”), whereby option holders agreed to surrender all options outstanding as of the closing of the Business Combination for cancellation effective immediately prior to the closing. In exchange for the cancellation of the vested and unvested options, option holders are entitled to right to receive payment of Option Cash Consideration equal to

$4,075,000 and Option Share Consideration,
 
of
432,500 common shares ($3,377,825
value)
 
in the surviving entity less applicable withholding taxes and without interest, paid on the first payroll cycle following the closing of the Business Combination. Upon the closing of the Business Combination, the Company recognized a liability for the fair value of the Option Cash Consideration and Option Share Consideration. An expense was recognized for the difference between the previously recognized portion of grant date fair value and the fair value of the recorded liability.
Stock based compensation expense during the three-month period ended September 
30
,
2021
, and September 
30
,
2020
was $
3.9
and $
0.3
 million respectively. Stock based compensation expense during the nine-month period ended September 
30
,
2021
and September 
30
,
2020
was $
4.6
 million and $
0.8
 million, respectively.
The Company has determined its share-based payments to be a Level 3 fair value measurement and has used the Black-Scholes option pricing model to calculate its fair value using the following assumptions:
 
    
September 30, 2020
 
Risk-free interest rate
    
1.58 - 2.47%
 
Expected term (life) of options (in years)
    
2-4
 
Expected dividends
     0%
 
Expected volatility
    
67.9 - 86.3%
 
The Company did not grant any awards during the nine month period ended September 30, 2021. The expected term of the options granted are determined based on the period of time the options are expected to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. In selecting similar entities for determining expected volatility, the Company considered industry, stage of life cycle, size and financial leverage. The dividend yield on the Company’s options is assumed to be zero since the Company has not historically paid dividends.
 
The following is a summary of the Company’s stock options as of September 30, 2021
 
and September
 
30, 2020 and the stock option activity from December 31, 2020 through September 30, 2021 and December 31, 2019 thro
u
gh September 30, 2020:
 
     
                     
     
                     
     
                     
     
                     
 
 
  
Number
of Options
 
  
Weighted
Average
Grant
Date Fair
Value
per
Option
(Amount)
 
  
Weighted
Average
Exercise
Price
(Amount)
 
  
Weighted
Average
Remaining
Contractual
Term
(Years)
 
                                                                                                                 
Balance, December 31, 2020
  
 
432,500
 
  
$
15.45
 
  
$
141.53
 
  
 
7.7
 
Granted
 
 
 
 
 
 
 
 
 
 
 
 
Exercised
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Forfeited
  
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Expired
  
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Cancelled
  
 
(432,500
)   
 
(15.45
)   
 
(141.53
)   
 
(7.7
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance, September 30, 2021
  
 
—  
 
  
$
—  
 
  
$
—  
 
  
 
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
     
                     
     
                     
     
                     
     
                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Number
of Options
 
  
Weighted
Average
Grant
Date Fair
Value
per
Option
(Amount)
 
  
Weighted
Average
Exercise
Price
(Amount)
 
  
Weighted
Average
Remaining
Contractual
Term
(Years)
 
                                                                                                                 
Balance, December 31, 2019
 
 
399,151
 
 
$
15.82
 
 
$
141.53
 
 
 
8.4
 
Granted
  
 
64,065
 
  
 
13.50
 
  
 
141.53
 
  
 
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Exercised
  
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Forfeited
  
 
(30,716
)   
 
15.80
 
  
 
141.53
 
  
 
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Expired
  
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance, September 30, 2020
  
 
432,500
 
  
$
15.45
 
  
$
141.53
 
  
 
7.9
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The number of options, weighted average grant date fair value per option, and weighted average exercise price in the table above have been revised from those disclosed in the previously issued unaudited quarterly financial statements for the periods ended September 30, 2021 and 2020 to reflect the exchange ratio implied by the ultimate settlement of the Company’s stock options on the Closing Date. These adjustments had no effect on the Company’s consolidated balance sheets, and statements of operations, comprehensive loss, temporary equity and stockholders’ (deficit) equity, and cash flows for any period presented herein. The Company has concluded that this revision is not material to the unaudited quarterly financial statements for the periods ended September 30, 2021 and 2020.
The following is a summary of the Company’s share-based compensation expense during the respective three-month and nine-month reporting periods:
 
 
  
Three months ended
September 30,
 
  
Nine months ended
September 30,
 
(in ‘000)
  
2021
 
  
2020
 
  
2021
 
  
2020
 
Total share-based compensation expense
   $  3,933      $  315      $  4,564      $  846  
As of September 30, 2021, there was no unrecognized compensation cost related to outstanding stock options.
NOTE 11 – SHARE-BASED PAYMENT AND RELATED STOCK OPTION PLAN
During 2020 and 2019, the Company granted awards to certain employees and board members of the Company. Under the 2014 Equity Incentive Plan (the “Plan”), the board is authorized to grant stock options to eligible employees, and directors of the Company. The fair value of the options is expensed on a straight-line basis over the requisite service period, which is generally the vesting period. Stock based compensation during the years ended December 31, 2020 and 2019 was $1.2 million and $1.7 million, respectively.
On March 12, 2021 and in connection with the Business Combination a modification in the existing terms of the options was introduced to add a contingent cash-settlement feature pursuant to which each option holder entered into option cancellation agreement (“Cancellation Agreements”), whereby option holders agreed to surrender all options outstanding as of the closing of the Business Combination for cancellation effective immediately prior to the closing. In exchange for the cancellation of the vested and unvested options, option holders are entitled to right to receive payment of Option Cash Consideration equal to $4,075,000 and Option Share Consideration of 432,500 common shares ($4,325,000 value) in the surviving entity less applicable withholding taxes and without interest, paid on the first payroll cycle following the closing of the Business Combination.
The Company has determined its share-based payments to be a Level 3 fair value measurement and has used the Black-Scholes option pricing model to calculate its fair value using the following assumptions:
 
    
December 31,
2020
   
December 31,
2019
 
Risk-free interest rate
     1.58     1.58 – 2.47
Expected term (life) of options (in years)
     2       2 – 4  
Expected dividends
     0     0
Expected volatility
     86.3     67.9 – 86.3
The expected term of the options granted are determined based on the period of time the options are expected to be outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. In determining similar entities, the Company considered industry, stage of life cycle, size and financial leverage. The dividend yield on the Company’s options is assumed to be zero since the Company has not historically paid dividends. The fair value of the underlying Company options was determined using the Black Scholes method.
The following is a summary of the Company’s stock options as of December 31, 2020 and the st
o
ck option activity from January 1, 2019 through December 31, 2020:
 
 
  
Number of
Options
 
  
Weighted
Average Grant
Date Fair Value
per Option
(Amount)
 
  
Weighted
Average
Exercise Price
(Amount)
 
  
Weighted Average
Remaining
Contractual Term
(Years)
 
Balance, December 31, 2018
 
 
414,434
 
 
$
15.80
 
 
$
141.53
 
 
 
9.3
 
Granted
     52,083        15.91        141.53           
Exercised
     —          —          —             
Forfeited
     (67,366 )      15.80        141.53           
Expired
     —          —          —             
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance, December 31, 2019
  
 
399,151
 
  
 
15.82
 
  
 
141.53
 
  
 
8.4
 
Granted
     64,064        13.50        141.53           
Exercised
     —          —          —             
Forfeited
     (30,715 )      15.80        141.53           
Expired
     —          —          —             
    
 
 
    
 
 
    
 
 
    
 
 
 
Balance, December 31, 2020
  
 
432,500
 
  
$
15.45
 
  
$
141.53
 
  
 
7.7
 
    
 
 
    
 
 
    
 
 
    
 
 
 
The following is a summary of the Company’s share-based compensation expense as of December 31, 2020 and 2019:
 
(in ‘000)
  
December 31,
2020
    
December 31,
2019
 
Total share-based compensation expense
   $ 1,161      $ 1,682  
Unrecognized compensation cost
     3,416        3,793  
Remaining recognition period (in years)
     2.7        3.4  
The following is a summary of the Company’s exercisable stock options as of December 31, 2020 and 2019:
 
 
  
December 31, 2020
 
  
December 31, 2019
 
                 
Range of exercise prices
   $ 80.87 – $202.18      $ 80.87 – $202.18  
Number
     153,898        85,110  
Weighted average remaining contractual term (in years)
     7.3        8.3  
Weighted average exercise price
   $ 141.53      $ 141.53  
The fair value of the Company’s vested shares for the
 
years ended December 31, 2020 and 2019 were $2.5 million and $1.3 million, respectively. The aggregate intrinsic value of options outstanding as of December 31, 2020 was $8.9 million. The intrinsic value of options exercisable was $2.6 million as of December 31, 2020. The total intrinsic value of options exercised was $0 for the years ended December 31, 2020 and 2019, respectively.